Although aerobic glycolysis can provide survival advantages to LARC during NAT, standard oxidative phosphorylation through the TCA cycle (Fig. 4) will contribute a significant role to the metabolic reprogramming of CRC cells to neutralise ROS. This evidence concerns the gene BRD2 and colorectal carcinoma.